Pyramax®

About Shinpoong Pharm

Shinpoong Pharmaceutical has established itself as a critical global supplier of malaria treatments, with a mission to improve public health in underserved regions through effective and affordable anti-infectives. Its core achievement is the development and global commercialization of sophisticated fixed-dose ACTs, including Pyramax®. The company's strategy leverages its deep formulation and regulatory expertise to expand its infectious disease portfolio, pursue geographic growth, and enhance its manufacturing and quality systems, as evidenced by recent ISO certifications and 2026 business initiatives.

Therapeutic Areas